![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25642-25650, September 3, 1999
From the Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel
| |
ABSTRACT |
|---|
|
|
|---|
Analysis of the trypanosomatid Leptomonas
collosoma 7SL RNA revealed the existence of two distinct stable
7SL RNA conformers (7SL I and II). Sequence analysis of the RNAs
indicated a single base difference between the conformers at position
133 (C in 7SL II and U in 7SL I) located in domain III. This change
appears to be the result of a post-transcriptional editing event, since the single-copy 7SL RNA gene codes exclusively for a C at this position. The edited form (7SL I) was found preferentially in the
cytoplasm, and the pre-edited form in the nucleus. 7SL I is mainly
bound to ribosomes, whereas 7SL II is more abundant in ribosome-free
particles. Mutations introduced in regions outside the editing site
were found to occur in a single conformation, suggesting that the
editing event is not the only factor that determines the conformation
of the molecule. This study is the first description of an editing
event on a small RNA other than tRNA and is the first report of C The signal recognition particle
(SRP)1 functions as an
adaptor between the protein synthesis machinery and the protein
translocation apparatus (1). SRP was shown in vitro to bind
the signal sequence emerging from translating ribosomes and to trigger
a transient pause in elongation. The arrest in translation was
documented by canine SRP in a wheat-germ cell-free system (2) but not when canine SRP was added to either reticulocyte lysate or HeLa cell
extracts (3). However, SRP was shown to cause translational pausing at
multiple sites in the nascent polypeptide in reticulocyte lysates (4).
In the second step of the SRP cycle, elongation arrest is relieved when
SRP interacts with the SRP receptor. The SRP is released and can
recycle, whereas the ribosome remains attached to the membrane and the
nascent chain is then translocated co-translationally into the lumen of
the endoplasmic reticulum (ER).
The best studied eukaryotic SRP is the canine particle that is composed
of one RNA molecule, the 7SL RNA, and six proteins: SRPs 9, 14, 19, 54, 68, and 72 (5). In vitro studies with canine SRP indicated
that SRP54 binds the signal peptide as it emerges from the ribosome,
SRP9/14 bind to domain I and function in elongation arrest, SRP68/72
promote translocation into the ER, whereas SRP19 facilitates the
binding of SRP54 to the RNA (6). SRP exists in the cell in different
states. About 15% of the SRPs are found as free (~11 S) particles,
and the remainder are divided almost equally between ribosomes and
microsomal membranes (7). The association of SRPs to monosomes is weak
compared with its tight binding to polysomes (7).
7SL RNA was cloned and sequenced from a variety of eukaryotes and these
RNAs appear to fit a canonical secondary structure model (8). Despite
extensive phylogenetic studies on the 7SL RNA, the only experimental
data supporting the secondary structure model are the nuclease
digestion (9) and The exact function of the 7SL RNA within the SRP complex is unknown.
7SL RNA most probably does not function simply as a passive scaffold
for the SRP proteins but rather has an active role in the translocation
process. SRP may therefore undergo structural rearrangements during the
functional cycle of the SRP. Indeed, one study, performed on soluble
polysome-bound and membrane-bound SRPs, revealed that the secondary
structure of the 7SL RNA in these particles is different, suggesting
that the 7SL RNA may play an active role in the SRP cycle (14). The
potential for the 7SL RNA to exist in more than one conformation was
observed for human 7SL RNA (14-16) and the sequences that are
essential for adopting the different conformations were determined (15, 16).
RNA editing is a process that co or post-transcriptionally modifies RNA
primary sequence from that encoded by the gene by either deletion,
insertion, or base modification (17). The phenomenon was first
described in trypanosomatid mitochondrial mRNA and was shown to
occur through a guide RNA-mediated cleavage and ligation (18). RNA
editing has since been found in diverse lower and higher eukaryotes.
The process can occur in the nucleus, chloroplast, and mitochondria,
and it involves base modification such as C In this study, we demonstrate that the L. collosoma 7SL RNA
is present in the cell in two stable conformational states. The conformational change is associated with an RNA editing event of C Primers to 7SL RNA--
5277 (5'-GCTTCACAGGATCG-3') is
complementary to nt 265-278; 17208 (5'-TGCTCCGTTGCCGGCCT-3') is
antisense to domain IV, complementary to nt 180-197; 8721 (5'-CGGGATCCAGCCGGAGCCTTGCTC-3') is sense to position 1-16 including a
BamHI site; 15137 (5'-CCGGATCCGGTGCGATGAAATGAGACGG-3') is
complementary to nt 304-323 including BamHI site; 16865 (5'-ATCAGATGCCGGTAGTC-3') is complementary to nt 72-86 of snoRNA-2
(19).
Growth and Extract Preparation--
L. collosoma
cells were grown as described previously (20). Cells (5 × 1010) were harvested, washed with phosphate-buffered
saline, and resuspended in buffer A containing 35 mM
Hepes-KOH (pH 7.9), 10 mM MgCl2, 50 mM KCl, 5 µg ml Plasmid Construction and DNA Transformation--
The
construction of mutants in domains II and IV was as described
previously (13). The 7SL RNA mutant carrying the double domain I was
constructed by ligating to the construct (pdI) carrying the 7SL RNA
domain I and 1.3 upstream sequence (13) a (335-base pair) polymerase
chain reaction product generated with oligonucleotide 8721 and 15137 and carrying the 7SL RNA coding region and its transcription
termination signals. The fragments carrying the mutations were cloned
into the pX expression vector (22). L. collosoma cells were
transfected with 50-100 µg of plasmid DNA, and stable cell lines
were generated as described previously (22).
7SL RNA Preparation and Modification with Diethyl Pyrocarbonate
(DEPC)--
Fractions enriched with 7SL RNA obtained from PRS prepared
from 1011 cells was fractionated on a DEAE-Sephacel column
(13), and the flow-through fraction was concentrated on 0.2-ml DEAE
column by binding the RNPs at 50 mM KCl and eluting at 0.4 M KCl. The RNA was deproteinized and separated on
preparative 10% denaturing gels. The 7SL RNA molecules were eluted
from the gel in 0.4 M sodium acetate, 0.1% SDS, 0.1 mM EDTA; 2-5 µg of pure 7SL RNA were obtained from each
preparative gel. Modification with DEPC was performed using 0.1 µg of
pure 7SL RNA as described previously (23). RNA was suspended in 300 µl of buffer II containing 200 mM Hepes (pH 8.0), 1 mM EDTA. 10 µl of DEPC was added, and incubation was for
45 min at 30 °C and 1 min at 90 °C. The reaction was terminated by chilling on ice, 5 µg of tRNA was added, and the RNA was
precipitated and analyzed by primer extension.
Primer Extension--
Total RNA (20 µg) was mixed with 50,000 cpm of gel-purified [ Preparation of Nuclei--
L. collosoma cells (2 × 109) were pelleted, washed with phosphate-buffered
saline, and suspended in buffer A. Nonidet P-40 was added to the
swollen cells to 0.3% % (v/v), and the cells were lysed by douching
20-30 times with a type "A" pestle. After microscopic examination
the nuclei were pelleted at 10,000 × g. The pellet and
cytoplasmic fractions were deproteinized, and the RNA was separated
on a denaturing gel and subjected to Northern analysis.
RNA Labeling and Sequencing--
Isolation of preparative
amounts of 7SL I and II was as described above. The individual 7SL RNA
molecules were eluted from the gel. The RNA was treated with alkaline
phosphatase to remove the phosphate termini and was 5'-end-labeled with
[ The L. collosoma 7SL RNA Is Present in Cells in Two Stable RNA
Conformations--
We have previously demonstrated that 7SL RNA is a
single-copy gene in L. collosoma and that no allelic
differences exist in this gene (13). However, two stable 7SL RNA
molecules were observed when RNA from L. collosoma was
fractionated on a 6% polyacrylamide denaturing gel (13). To examine
whether the two transcripts represent two distinct RNA structures, the
migration of the RNA was examined in urea gels that vary in the
percentage of polyacrylamide. In addition, the migration was examined
in gels containing both urea and formamide and in native gels. The
results, presented in Fig. 1, indicate
that the apparent mobility of 7SL I and II relative to the DNA marker
varied in gels containing different acrylamide concentrations,
suggesting that both molecules migrate abnormally not as linear RNA
molecules. This is surprising since the 7 M concentration
of urea used in these gels is assumed to provide totally denaturing
conditions. Such partial denaturation phenomenon was previously
reported for the Escherichia coli 5 S rRNA (26). Our data,
as well as the 5 S rRNA study, suggest that in the presence of 7 M urea, under standard electrophoresis conditions, most,
but not all, secondary structures are melted. The RNA migrated as a
single molecule or form, approximately at the expected size, only in
the presence of 75% formamide and 7 M urea. In native
gels, however, four 7SL RNA bands were observed, since each of the
single conformations, i.e. 7SL I (the fast migrating form)
and 7 SL II (the slow migrating from), can be further separated into
two bands. The ability to denature the RNA under very stringent denaturation conditions suggests that none of the secondary or tertiary
RNA structures are stabilized by the formation of covalent bonds.
The Level of 7SL I and II Changes during Growth and Is Affected
When Protein Synthesis Is Inhibited--
To explore whether the two
7SL conformers represent two functional forms of the molecule, the
level of the two conformers was first examined during growth. The
results (Fig. 2A) indicate that the level of 7SL I to II changes during growth, suggesting that in
actively growing and metabolizing cells the dominant form is 7SL I. To
control for the amount of RNA in each lane, the level of another stable
RNA, U3, was examined. The results indicate that the amount of RNA was
comparable in each lane and that the level of U3 did not change during
growth.
To correlate the conformational change with the translation process,
the level of the two conformers was examined when protein synthesis was
inhibited by cycloheximide. The results presented in Fig. 2B
indicate that, upon inhibition of protein synthesis with cycloheximide,
the high ratio of 7SL I to 7SL II remained constant (~1.7), whereas
in the control the ratio decreased from 1.7 to 0.9. These results
suggest that inhibition of translation, and consequently protein
translocation, arrests the conversion process and may therefore suggest
that the conformational change takes place only during ongoing protein synthesis.
Studies of the mammalian 7SL RNA indicate that the 7SL RNA undergoes
conformational changes during the translocation cycle (14). This
conclusion is based on differential chemical sensitivity of the 7SL RNA
found in free particles versus polysome-bound or membrane-bound SRPs (14). To explore whether 7SL I and II are associated with different subpopulations of the SRP, the level of 7SL
RNA was examined on free and ribosome-bound SRPs. Low salt, whole cell
extract was fractionated on sucrose gradients. RNA was extracted from
the gradient fractions and subjected to Northern analysis with
antisense 7SL RNA probe. The RNA profile across the gradient and the
Northern analysis with 7SL RNA probe is presented in Fig.
3A. Densitometric analyses of
the results indicate that 7SL I is preferentially associated with
ribosomes since the ratio of 7SL I to 7SL II is higher in
ribosome-enriched fractions (fraction 18). The ratio between 7SL I and
7SL II was also examined in the ribosomal and post-ribosomal fractions.
The data suggest that the ratio between 7SL I to 7SL II are higher in
the ribosomal fraction than in PRS (Fig. 3B). The
densitometric analysis in Fig. 3B is representative of five
independent experiments.
Differences between 7SL I and 7SL II Revealed by Partial Enzymatic
Cleavage with Base Specific Nucleases--
The sequence of four
independent 7SL RNA genes cloned in our laboratory was identical (13).
Therefore, changes in sequence of 7SL I and 7SL II may take place
post-transcriptionally. To directly analyze the RNA sequence and to
obtain information on the RNA structure, the susceptibility to
nucleases was examined. For this purpose, the purified 7SL RNA species
were separately end-labeled and subjected to partial hydrolysis with
base-specific nucleases. The results presented in Fig.
4 indicate that the two 7SL molecules are
very stable and that there is no conversion in vitro between
these species, i.e. 7SL I was not converted to II or
vice versa. The sequences seem to be identical except for position C138 in loop III. Ribonuclease CL3 digested the C in 7SL I but
not in 7SL II. The failure to digest this C may result from base
modification, since it has been reported that modified bases are less
susceptible to digestion with nucleases (27). It should be noted that
7SL RNA is among the few small RNAs that were shown not to carry
modified bases. Indeed, this is the case for the L. collosoma 7SL RNA. 7SL I and II were analyzed for the presence of
modified nt using high performance liquid chromatography and mass
spectrometry and no modified nt were
detected.3 The reason for the
peculiar lack of digestion of C138 in 7SL II may result from its
inaccessibility to the nucleases due to local secondary structure of
the RNA. It is known that secondary structure interferes with the
cleavage of site-specific nucleases (28). Additional evidence for the
existence of stable structures in 7SL RNA is the presence of
compression in the sequence. The compressed regions are marked with
brackets in Fig. 4, and are located between loop III and the
loop around nt 160. These compressed regions are, however, common to
both molecules.
Analysis of the 7SL I and II Structures Using AMV Reverse
Transcriptase and Differential Sensitivity of 7SL I and II to
Modification with DEPC--
It is well documented that the presence of
highly structured regions in an RNA molecule induces the reverse
transcriptase to pause. We have used this property of reverse
transcriptase to monitor differences in the structures of 7SL I and II.
Primer extension was performed on the two separated 7SL RNA molecules. The results are presented in Fig. 5
(A and B) and indicate that stops common to both
molecules are located in the 3' part of domain II and IV. However,
there are also stops that are unique to both 7SL I or 7SL II and these
are indicated in Fig. 5C. In all the experiments that we
have performed, the number of stops on 7SL II was higher compared with
7SL I. Because of the numerous strong stops on 7SL II, the level of the
extension product from 7SL II that reached the +1 position was only
1/10 of that observed for 7SL I. Most of the unique stops on 7SL II
were mapped to domain II in the region adjacent to domain III and in
domain III itself.
To further elucidate the structure of the two molecules, each 7SL RNA
conformer was exposed to chemical modifications and the locations of
the modified sites were mapped by primer extension. To differentiate
natural reverse transcriptase stops from stops elicited by chemical
modification, untreated RNA sample was analyzed next to the chemically
modified RNA. The experiments were performed with both dimethyl sulfate
and DEPC. Because dimethyl sulfate modifies both guanosine and cytosine
(23) and since the G+C content of 7SL RNA is 65%, the modification
created many obstacles for the reverse transcriptase. Only very short
extension products were obtained and therefore the data could not be
used to deduce structural information on the two molecules. However,
treating the RNA with DEPC, which modifies adenines (23), revealed that 7SL I is more susceptible to the chemical compared with 7SL II, as
presented in Fig. 6. The location of the
modified bases is indicated in Fig. 5C. The reverse
transcriptase stops were located one nucleotide before the modified
base as was previously reported (29). This data suggests that 7SL I
have a more open structure and therefore is more accessible to chemical
modifications. Most of the modified bases are located in domains I and
II of the RNA, suggesting differences in the structures of these
domains between the two conformers. However, the differential pause
sites on domain III (observed in Figs. 5 and 6) suggests differences
also in the structure of this domain. These differences may have not
been revealed by the DEPC treatment because few adenines exist in this domain.
An Editing Event Is Associated with the Two 7SL RNA
Conformers--
To examine whether the differences between the 7SL
molecules could also be attributed to minor sequence differences that
are introduced post-transcriptionally, the separated RNA molecules were
subjected to primer extension sequencing. The results, presented in
Fig. 7, demonstrate a single change. This
change was mapped to position 133 where a U was found in 7SL I
versus a C in 7SL II. The DNA sequence of all four
independently cloned 7SL RNA genes indicate the presence of C at this
position, suggesting that the C 7SL RNA Mutated in Strategic Domains of the Molecule, but Located
outside the Editing Site, Are Found in a Single Conformation--
To
relate the functionality of the 7SL RNP with the conformational change
of the 7SL RNA undergoes, the conformation of three 7SL RNA mutants was
examined in vivo. Cells lines expressing 7SL RNA genes
mutated in strategic domains of the 7SL RNA were prepared (Fig.
9A). One mutant carries an
insertion in the most conserved loop IV, which should affect the
binding of the SRP54 protein; the second mutant carries an insertion in
domain II in the region shown in the mammalian 7SL RNA to interact with
ribosomes (14); and the third mutant carries a double domain I. RNA was
prepared from cell lines expressing the mutated 7SL RNA genes and was
subjected to Northern analysis with 7SL RNA probe. The results,
presented in Fig. 9B, indicate that mutations in either
domain II or IV expressed form the multicopy plasmid repressed the
synthesis of the wild type 7SL RNA as shown by the disappearance of the
wild type 7SL I and II transcripts (13). These mutants failed to undergo the conformational change, and the mutated 7SL RNA appeared as
a single transcript, since the same hybridization pattern was observed
when the RNA was hybridized with a specific probe that detects the
mutant but not the wild type RNA (results not shown). However, the 7SL
RNA carrying the double domain I failed to repress the synthesis of the
wild type RNA, but did not undergo the conformational change.
Hybridization with a probe designed to specifically identify the
mutated RNA (antisense to the boundary between the two domains I) was
used to confirm that the mutated 7SL RNA is present in a single
conformation (results not shown). These results suggest that mutated
7SL RNA that engage inactive particles fail to undergo the
conformational change.
This study demonstrates that the trypanosomatid 7SL RNA undergoes
a conformational change in vivo that is associated with an
RNA editing event. This is the first description of a C The L. collosoma 7SL RNA, unlike all 7SL RNA described so
far, is not fully denatured in 7 M urea. Such a property
was previously observed for E. coli 5 S rRNA (26). In the
latter case, the fast migrating molecule carried a U in position 92, whereas the slow migrating variant contained a C in the same position
(26). This is exactly the case in this study, since the fast migrating 7SL I carries a U in position 133 and the slow migrating molecule (7SL
II) carries a C in the same position. In the case of the 5 S rRNA, it
was suggested that the only difference observed between the two
variants is responsible for the drastic reduction in the stability of
the two 5 S rRNA molecules (26). It is currently unknown whether this
is also the case in the L. collosoma 7SL RNA. However, the
findings that mutated 7SL RNAs located outside the editing site were
found in a single conformation may suggest that the editing is not the
only factor that controls the structural change. The mechanism that
elicits the conformational change of 7SL RNA is unknown. Since the
editing site is situated close to loop III and to the region that was
shown to bind SRP19 in the canine SRP (30), it may alter SRP19 binding.
Alternatively, the editing event may affect long range tertiary interactions.
The differences in pause sites observed between 7SL I and 7SL II may
represent regions on the molecule that present obstacles for reverse
transcriptase due to RNA structures that are not melted because of
strong secondary or tertiary interactions. The differential stops
between 7SL I and 7SL II reflect differences in the structures of the
two molecules. These different structures are mostly located in domains
II and III. Previous studies performed on naked human 7SL RNA indicated
that in vitro transcribed human 7SL RNA can exist in two
different conformations that can be separated on native gels (15, 16).
By site-directed mutagenesis, different sites were shown to be
important for the formation of these two conformations. Most of the
mutations affecting the conformation of the RNA were located in domains
II and III of the RNA (16). These are also the domains where major
differences were seen in stop sites between the trypanosomatid 7SL I
and II. A small region located between positions 129 to 134 of the
mammalian 7SL RNA, which is part of the SRP 19 binding site was shown
to be most critical for the conformational change that the mammalian
7SL RNA undergoes (16). The editing site detected in this study is
located in this same domain.
Studies performed on ribosome-bound, membrane-bound, and free canine
SRPs have indicated that the 7SL RNAs in these SRPs are found in
different conformations. This conclusion was based on variation in
sensitivity of the different SRPs to chemical modifications (14).
Initially, it was expected that polysome-bound SRP should be less
sensitive to chemical modification than free SRPs because of potential
protection of the particles by ribosomes. Instead, the converse was
found, and chemical accessibility of polysome-bound SRP was actually
higher than that of soluble SRPs, suggesting that the polysome-bound
SRP has a more open conformation than that of the 7SL RNA in free
particles (14). The results presented in this study supports this
notion, since 7SL I, which is preferentially associated with ribosomes,
is the molecule that was found to be more accessible to chemical
modification and therefore has a more open structure, whereas the 7SL
II, which is found mostly associated with free SRPs possesses a more
closed structure, as revealed by the many strong pause sites and
inaccessibility to modification by DEPC. The location of the pause
sites observed on the 7SL RNA agrees well with the regions that were
shown to be involved in binding to ribosomes or to the rough ER
membrane (14). In particular, attention should be drawn to the region
around nt 120 in domain III, since homologous regions on the mammalian
7SL RNA were shown to bind to ribosomes or the ER membrane. In
addition, the regions in domain II around nt 220 were also shown in the
mammalian system to be involved in binding to ribosomes or ER membrane
(14). Interestingly, only domain I of the 7SL I but not of 7SL II was accessible to interaction with DEPC, suggesting major differences in
the structure of this Alu-like domain between the conformers. In the
mammalian SRP, however, the Alu domain was less accessible to chemical
modification compared with S domains II and III (14).
It is currently unknown why the 7SL RNA undergoes a conformational
change during the translocation cycle. Two steps in the translocation
cycle may require changes in the 7SL RNA: first when SRP interacts with
the ribosome and induces an arrest or a pause in translation, and again
when SRP is released from the ribosome after its interaction with the
SRP receptor (1). Conformational changes of rRNA have been shown to
take place in the transition from inactive to active 30 S ribosomal
subunits (31), in the assembly of subunits to monosomes (32) and during
tRNA translocation (33). In this context, the 7SL RNA may cause
translation arrest by interacting with the rRNA, thus interfering with
the conformational changes rRNA undergoes during protein synthesis.
However, the arrest function of SRP was shown to be mediated by domain
I (6). It has been suggested that domain I functions in protein arrest by mimicking the shape of a tRNA and thereby blocking the entry of
incoming tRNAs. Our finding that a tRNA-like molecule is present in the
SRP complex in a 1:1 ratio with the 7SL RNA supports the notion that
the tRNA-like domain may play a role in the arrest (2). The data
presented in this paper, as well as the studies on the canine SRP (14)
demonstrating that the structure of domains II and III are different in
ribosome-free and ribosome-bound SRP, suggest that additional
interactions apart from the domain I but with domains II and III of the
molecule are also essential for the interaction of the SRP with the
ribosome. Further studies are needed to accurately map the site of
interaction of 7SL RNA with rRNA, e.g. by in vivo
UV-induced psoralen cross-linking.
C The finding of C The localization of 7SL I in the cytoplasmic fraction suggests that
this editing takes place in the cytoplasm. We could not, however, rule
out the possibility that editing takes place in the nucleus and that
the edited RNA is rapidly translocated to the cytoplasm. The finding
that 7SL RNA mutants examined in this study exist in a single
conformation may suggest that only 7SL RNA molecules that engage active
particles undergo the conformational change. We therefore favor the
hypothesis that the editing function may be associated with the
ribosome. This hypothesis is not unprecedented, since
deaminases involved in editing were found in the cytoplasm of plants
(34).
The combination of the unique properties of the L. collosoma
7SL RNA with the ability to express in vivo mutated 7SL RNA
will be further used to identify sequences that are involved in:
(a) the editing event, (b) the ability to undergo
the conformational change, and (c) binding of ribosomes. The
establishment of an in vitro system that is amenable to
convert 7SL II is essential for better understanding the mechanism and
machinery that carries out this novel editing event. We anticipate that
other editing events of C
U
editing in trypanosomes. We propose a novel role for RNA editing in
controlling the conformation of the 7SL RNA in vivo.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-sarcin cleavage data (10). The trypanosome 7SL
RNA also fits the canonical secondary structure model, except that
domain I appear to deviate in length and structure from the human RNA
(11-13). Only 70% identity exists between the 7SL RNAs of the
monogenetic trypanosomatid Leptomonas collosoma and
Trypanosoma brucei (13). Whereas domains I and IV of these
trypanosomatid 7SL RNAs are highly conserved, domain III is divergent
(13). The presence of a co-migrating tRNA-like molecule, which
co-purifies with the T. brucei 7SL RNA (12), led us to
hypothesize that the trypanosomatid SRP may differ from other SRPs and
is composed of two small RNAs. Using affinity selection with antisense
biotinylated oligonucleotide, we have recently demonstrated that
L. collosoma SRP complex is indeed composed of two RNA
molecules, the 7SL RNA and a tRNA-like molecule
(sRNA-85).2
U, U
C, and A
I
transitions on mRNAs (17). RNA editing was also shown to alter the
sequence of tRNA and rRNA (17).
U conversion at position 133. This event, however, is not the only
factor that determines whether 7SL RNA will undergo the structural
changes, since 7SL RNA mutants, altered in regions outside the editing
site, were found in a single conformation. The conversion between the
two conformations is a dynamic process that takes place in the
cytoplasm; 7SL I was also found preferentially attached to ribosomes.
This is the first report that correlates conformational change of a
small RNA molecule with RNA editing and is the first to report the
existence of C
U editing in trypanosomes.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 leupeptin, and 5 mM
-mercaptoethanol. The cell suspension was equilibrated in a nitrogen cavitation bomb (Parr Instruments Co.) at
1000 p.s.i. for 10 min, and disrupted by release from the bomb (20). Post-ribosomal supernatant (PRS) was prepared as described previously (21).
-32P]ATP-labeled oligonucleotide
(~1 pmol). After annealing at 60 °C for 15 min, the sample was
kept on ice for 1 min, 1 unit of AMV reverse transcriptase was added,
and the extension was performed at 42 °C for 90 min. The reaction
was analyzed on a 6% polyacrylamide denaturing gel next to DNA
sequencing reaction performed with the same primer. Primer extension
sequencing was performed as described previously (24).
-32P]ATP (3000 Ci mmol
1) and
polynucleotide kinase (25). Aliquots of the labeled RNA were partially
digested with base-specific nucleases RNaseT1 (G), U2 (A), CL3 (C),
PhyM (A+U), and Bacillus cereus (C+U), according to the
supplier's instructions. The alkaline partial hydrolysis ladder was
produced by boiling the RNA for 2 min in 50 mM NaOH solution containing 1 mM EDTA.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (50K):
[in a new window]
Fig. 1.
Separation of the 7SL RNA in polyacrylamide
gels. Fractions enriched in 7SL RNP obtained from a DEAE-Sephacel
column were deproteinized, and the RNA was separated in different gel
systems next to a DNA marker (M; 1-kilobase pair ladder,
Life Technologies, Inc.). The RNA was visualized by EtBr staining. RNA
was separated in 6% polyacrylamide gel containing 7 M urea
(A), 10% polyacrylamide gel containing 7 M urea
(B), 10% polyacrylamide containing 75% formamide and 7 M urea (C), and 10% native polyacrylamide gel
(D).

View larger version (21K):
[in a new window]
Fig. 2.
The ratio between 7 SL I to 7 SL II during
growth and upon treatment with cycloheximide. A,
L. collosoma cells were grown for 60 h. Every 6 h
cells were counted. RNA was prepared from cells every 12 h and
subjected to Northern analysis with anti-7SL and anti-U3
oligonucleotide probes. The growth curve and the Northern analysis with
the probes are presented. Densitometric analysis was performed, and the
ratio between 7SL I and II was determined and is schematically
presented. B, L. collosoma cells (5 × 106/ml) were grown for 50 h in the presence of 200 µg ml
1 cycloheximide. RNA was prepared from control and
treated cells and was subjected to Northern analysis with anti-7SL and
U3 oligonucleotide probes. The data were subjected to densitometric
analysis, and the ratio between 7SL I and II was determined and is
schematically presented. The squares represent the ratio
between 7SL I and II in control cells, and the circles
indicate the ratio in cells treated with cycloheximide.

View larger version (44K):
[in a new window]
Fig. 3.
A, fractionation of 7SL RNP on sucrose
gradients. Low salt, whole cell extracts were layered on a continuous
10-30% (w/v) sucrose gradient in buffer A containing 100 mM KCl. Gradients were centrifuged at 4 °C for 3 h
at 35,000 rpm in a Beckman SW41 rotor. S values were determined using
standards, i.e. 30, 50, and 70 S ribosomes from E. coli and the enzyme catalase (10 S). RNA was extracted and
separated on a 10% denaturing gel. The RNA was stained with EtBr and
was subjected to Northern analysis with antisense oligonucleotide
probes to the 7SL and 5 S RNA. The level of 7SL I to II across the
gradient was determined by densitometric analysis and the ratio between
7SL I to 7SL II is presented. B, the distribution of 7SL I
and II on ribosomes and PRS. Low salt, whole cell extracts was
subjected to high speed spin (150,000 × g). RNA was
extracted from the ribosomal pellet and PRS and subjected to Northern
analysis with 7SL and 5S RNA probes. Densitometric analysis was
performed on the level of 7SL I and II, and the ratio between the two
molecules is presented. The results are expressed as mean ± S.E.
(n = 5) *, p < 0.05.

View larger version (87K):
[in a new window]
Fig. 4.
Partial enzymatic sequence determination of
7SL RNA. 7SL RNA, enriched from a DEAE-Sephacel column fraction,
was separated on a 10% polyacrylamide gel containing 7 M
urea. The RNA was labeled at the 5' and separated on a 10% denaturing
sequencing gel. The individual 7SL I and II RNAs were subjected to
partial digestion with base-specific RNases. Lane G, guanine-specific RNase T1 ladder; lane A, adenine-specific RNase U2 ladder; lane AU, adenine-uridine-specific RNase phyM ladder;
lane C, cytosine-specific RNase CL3 ladder;
lane CU, cytosine-uridine-specific RNase B. cereus ladder; lane L, alkaline partial
hydrolysis ladder. The RNA sequence is indicated. The regions of the
RNA that were resistant to digestion are indicated with
brackets. The RNA sequence of loop III is indicated at the
left of the 7SL I sequence, and the C at position 138 is
designated with an arrow. The sequence of the loop spanning
positions 158-165 is indicated at the right of the 7SL II
sequence. Co, control untreated fragment.

View larger version (64K):
[in a new window]
Fig. 5.
A, mapping the AMV reverse transcriptase
pause sites on 7SL I and 7SL II. 7SL I and 7SL II were eluted from a
preparative gel, and ~100 ng were subjected to primer extension with:
1) oligonucleotide 5277, complementary to the 3' end of the molecule,
and 2) oligonucleotide 17208, complementary to loop IV. 7SL DNA
sequencing with the same oligonucleotides used for primer extension was
used as reference. Primer extension stops on 7SL I are indicated with
white arrows and those on 7SL II with
black arrows. B, primer extension
sequencing of 7SL I and II. RNA was prepared as in A. The
primer extension was performed with oligonucleotide 17208 in the
presence of dideoxynucleotides. The stops on 7SL I and II are indicated
with arrows as in A. C, localization
of the major AMV reverse transcriptase pause sites on the secondary
structure of the 7SL RNA. The structural stops on 7SL I and II are
indicated with gray and black arrows,
respectively. Stops elicited from the DEPC modification are indicated
with arrows and circles.

View larger version (49K):
[in a new window]
Fig. 6.
Primer extension of 7SL conformers before and
after DEPC treatment. Gel-purified 7SL I and II (0.1 µg) were
treated with DEPC as described under "Experimental Procedures." RNA
was analyzed by primer extension using oligonucleotide 17208. The + and
indicate samples that were treated or untreated with DEPC,
respectively. 7SL DNA sequencing with the same oligonucleotides used
for primer extension was used as reference, and only the T
lane is presented.
U conversion takes place
post-transcriptionally. To examine in which cell compartment (nucleus
or cytoplasm) this post-transcriptional modification may take place,
the cellular distribution of 7SL I and II was examined. To assess the
quality of the nuclei, the distribution of the small nucleolar RNA
snoRNA-2 RNA was assayed. RNA was prepared from the nuclear and
cytoplasmic fractions, and was subjected to Northern analysis with 7SL
and snoRNA-2 probes (Fig. 8). The
distributions of snoRNA-2 indicate that the nuclei were intact and no
snoRNA-2 leaked to the cytoplasm. 7SL I was preferentially found in the
cytoplasm; minor contamination of the nuclei by the cytoplasmic
fraction can explain the small amount of 7SL I found in the nuclear
fraction. The 7SL II was found exclusively in the nucleus, suggesting
that this conformer undergoes the conformational change and the editing
in the cytoplasm. However, we cannot rule out the possibility that
editing does take place in the nucleus and that the edited RNA is
rapidly translocated to the cytoplasm.

View larger version (53K):
[in a new window]
Fig. 7.
Primer extension sequencing of 7SL I and
II. RNA was prepared and analyzed as in Fig. 5B. The
sequence adjacent to C133 is indicated.

View larger version (26K):
[in a new window]
Fig. 8.
Northern analysis of nuclear and cytoplasmic
fractions. Cell fractionation was as described under
"Experimental Procedures." The blot was hybridized with antisense
7SL and snoRNA-2 probes. The DNA marker used was a 1-kilobase pair
ladder (Life Technologies, Inc.).

View larger version (14K):
[in a new window]
Fig. 9.
Northern analysis of RNA prepared from cell
lines carrying 7SL RNA mutants. A, schematic
presentation of the 7SL RNA mutants. The position and the sequence of
the oligonucleotide are indicated. B, Northern analysis of
RNA from cell lines carrying the mutated 7SL RNA genes. 1,
wild type RNA; 2, mutation in domain II; 3,
mutation in loop IV; 4, double domain I. The DNA marker used
was a 1-kilobase pair ladder (Life Technologies, Inc.).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
U editing
on a small RNA apart from tRNA, and is also the first case of C
U
editing in trypanosomes.
U conversion is among the best documented RNA editing events and
has been shown to take place in mitochondria, chloroplast, and the
nucleus (17). The first reported C
U editing by base deamination
was for the apolipoprotein B mRNA that takes place in the nucleus
post-transcriptionally (17). C
U editing was found also in the
mitochondria and chloroplast of land plants (34). This type of editing
is, however, not restricted to mRNA and was found to modify the
anticodon loop and acceptor stem of tRNAs (35). Whereas the editing of
apoB mRNA is directed by a mooring sequence located adjacent to the
editing site, tRNA editing, especially editing sites in the acceptor
stem, may be guided by the base-paired region opposite the edited
nucleotide (34, 35). This could also be the case for the 7SL RNA
editing, since the site is present in an 8-base pair stem-loop
structure. It is currently unknown what type of activity could mediate
the editing event revealed in this study. However, the conversion of C
U may "freeze" the 7SL I. Since the results presented in this
study suggest that the conversion of 7SL I to 7SL II is a dynamic
process, it may imply that an activity that mediates U
C conversion
should also exist to convert 7SL I to 7SL II. U
C editing was
reported mainly in the mitochondria and chloroplast of land plants and
mammalian tRNAs (34). This conversion could be achieved by transamination.
U editing in trypanosomes is especially
interesting because it suggests that U insertion and deletion present in the kinetoplast (18) is not the only editing pathway in trypanosomes and that two different mechanisms of editing can co-exist in the same
organism. Because of the early divergence of trypanosomes from the
eukaryotic lineage, the finding of C
U editing in trypanosomes suggests that this process evolved early in eukaryotic evolution.
U on small RNAs, such as tRNAs and other
cellular and kinetoplast mRNAs, may be found in trypanosomes.
| |
FOOTNOTES |
|---|
* This work was supported by a research grant from the Israel Academy of Sciences and Humanities.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Faculty of Life
Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel. Tel.: 972-3-5318068; Fax: 972-3-5351824.
2 H. Ben-Shlomo, Y.-X. Xu, L. Liu, Y. Zhang, I. Goncharov, and S. Michaeli, submitted for publication.
3 James A. McCloskey, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: SRP, signal recognition particle; ER, endoplasmic reticulum; RNP, ribonucleoprotein; nt, nucleotide(s); PRS, post-ribosomal supernatant; AMV, avian myeloblastosis virus; DEPC, diethyl pyrocarbonate; SL, spliced leader; snoRNA, small nucleolar RNA.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Walter, P., and Johnson, A. E. (1994) Annu. Rev. Cell Biol. 10, 87-119[CrossRef] |
| 2. |
Walter, P.,
and Blobel, G.
(1981)
J. Cell Biol.
91,
557-561 |
| 3. | Meyer, D. I. (1985) EMBO J. 4, 2031-2033[Medline] [Order article via Infotrieve] |
| 4. |
Wolin, S. L.,
and Walter, P.
(1993)
J. Cell Biol.
121,
1211-1219 |
| 5. | Walter, P., and Blobel, G. (1982) Nature 299, 691-698[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Siegel, V., and Walter, P. (1988) Trends Biochem. Sci 3, 314-316 |
| 7. |
Walter, P.,
and Blobel, G.
(1983)
J. Cell Biol.
97,
1693-1699 |
| 8. |
Althoff, S.,
Selinger, D.,
and Wise, J. A.
(1994)
Nucleic Acids Res.
22,
1933-1947 |
| 9. | Gundelfinger, E. D., Carlo, M. D., Zopf, D., and Melli, M. (1984) EMBO J. 3, 2325-2332[Medline] [Order article via Infotrieve] |
| 10. |
Siegel, V.,
and Walter, P.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
1801-1805 |
| 11. | Michaeli, S., Podell, D., Agabian, N., and Ullu, E. (1992) Mol. Biochem. Parasitol. 1, 55-65 |
| 12. | Béjà, O., Ullu, E., and Michaeli, S. (1993) Mol. Biochem. Parasitol. 57, 223-230[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Ben-Shlomo, H.,
Levitan, A.,
Béjà, O.,
and Michaeli, S.
(1997)
Nucleic Acids Res.
25,
4977-4984 |
| 14. | Andreazzoli, M., and Gerbi, S. A. (1991) EMBO J. 10, 767-777[Medline] [Order article via Infotrieve] |
| 15. | Zwieb, C., and Ullu, E. (1986) Nucleic Acids Res. 4, 4639-4658 |
| 16. |
Gowda, K.,
and Zwieb, C.
(1997)
Nucleic Acids Res.
25,
2835-2840 |
| 17. | Smith, H. C., Gott, J. A., and Hanson, M. R. (1997) RNA 3, 1105-1123[Medline] [Order article via Infotrieve] |
| 18. | Stuart, K., Allen, T. E., Kable, M. L., and Lawson, S. (1997) Curr. Opin. Chem. Biol. 1, 340-346 [CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Levitan, A.,
Xu, Y. X.,
Ben-Dov, C.,
Ben-Shlomo, H.,
Zhang, Y.,
and Michaeli, S.
(1998)
Nucleic Acids Res.
26,
1775-1783 |
| 20. | Goldring, A., Karchi, M., and Michaeli, S. (1995) Exp. Parasitol. 80, 333-338[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Michaeli, S.,
Roberts, T. G.,
Watkins, K. P.,
and Agabian, N.
(1990)
J. Biol. Chem.
265,
10582-10588 |
| 22. | Goldring, A., Zimmer, Y., Ben-Yehuda, E., Goncharov, I., and Michaeli, S. (1996) Exp. Parasitol. 84, 28-41[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Krol, A., and Carbon, P. (1989) Methods Enzymol. 180, 212-227[Medline] [Order article via Infotrieve] |
| 24. |
Patzelt, E.,
Perry, K. L.,
and Agabian, N.
(1989)
Mol. Cell. Biol.
9,
4291-4297 |
| 25. | Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 26. | Digweed, M., Kumagai, I., Pieler, T., and Erdmann, V. A. (1982) Eur. J. Biochem. 127, 531-537[Medline] [Order article via Infotrieve] |
| 27. |
Donis-Keller, H.,
Maxam, A. M.,
and Gilbert, W.
(1997)
Nucleic Acids Res.
4,
2527-2538 |
| 28. |
Lockard, R. E.,
Alzner-Deweerd, B.,
Heckman, J. E.,
MacGee, J.,
Tabor, M. V.,
and RajBhandary, U. L.
(1978)
Nucleic Acids Res.
5,
37-56 |
| 29. |
Youvan, D. C.,
and Hearst, J. E.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
3751-3754 |
| 30. | Siegel, V., and Walter, P. (1988) Proc. Natl. Acad. Sci U. S. A. 85, 1801-1805 |
| 31. | Moazed, D., and Noller, H. F. (1986) Cell 47, 985-994[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Stebbins-Boaz, B., and Gerbi, S. A. (1990) J. Mol. Biol. 217, 93-112 |
| 33. | Moazed, D., and Noller, H. F. (1989) Nature 342, 142-148[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Marchfelder, A., Binder, S., Brennicke, A., and Knoop, V. (1998) in Modification and Editing of RNA (Grosjean, H. , and Benne, R., eds) , pp. 307-323, ASM Press, Washington, D. C. |
| 35. | Price, D., and Gray, M. W. (1998) in Modification and Editing of RNA (Grosjean, H. , and Benne, R., eds) , pp. 289-305, ASM Press, Washington, D. C. |
This article has been cited by other articles:
![]() |
Y. Lustig, Y. Vagima, H. Goldshmidt, A. Erlanger, V. Ozeri, J. Vince, M. J. McConville, D. M. Dwyer, S. M. Landfear, and S. Michaeli Down-Regulation of the Trypanosomatid Signal Recognition Particle Affects the Biogenesis of Polytopic Membrane Proteins but Not of Signal Peptide-Containing Proteins Eukaryot. Cell, October 1, 2007; 6(10): 1865 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. ZELAZNY, D. P. FEDORKO, L. LI, F. A. NEVA, and S. H. FISCHER EVALUATION OF 7SL RNA GENE SEQUENCES FOR THE IDENTIFICATION OF LEISHMANIA SPP. Am J Trop Med Hyg, April 1, 2005; 72(4): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. ZWIEB, R. W. VAN NUES, M. A. ROSENBLAD, J. D. BROWN, and T. SAMUELSSON A nomenclature for all signal recognition particle RNAs RNA, January 1, 2005; 11(1): 7 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, H. Ben-Shlomo, Y.-x. Xu, M. Z. Stern, I. Goncharov, Y. Zhang, and S. Michaeli The Trypanosomatid Signal Recognition Particle Consists of Two RNA Molecules, a 7SL RNA Homologue and a Novel tRNA-like Molecule J. Biol. Chem., May 9, 2003; 278(20): 18271 - 18280. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, X.-h. Liang, S. Uliel, R. Unger, E. Ullu, and S. Michaeli RNA Interference of Signal Peptide-binding Protein SRP54 Elicits Deleterious Effects and Protein Sorting Defects in Trypanosomes J. Biol. Chem., November 27, 2002; 277(49): 47348 - 47357. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Simpson, O. H. Thiemann, N. J. Savill, J. D. Alfonzo, and D. A. Maslov Evolution of RNA editing in trypanosome mitochondria PNAS, June 20, 2000; 97(13): 6986 - 6993. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||